chr6-39314100-A-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_031460.4(KCNK17):c.221T>A(p.Leu74Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000082 in 1,585,412 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000084 ( 0 hom. )
Consequence
KCNK17
NM_031460.4 missense
NM_031460.4 missense
Scores
5
8
6
Clinical Significance
Conservation
PhyloP100: 6.34
Genes affected
KCNK17 (HGNC:14465): (potassium two pore domain channel subfamily K member 17) The protein encoded by this gene belongs to the family of potassium channel proteins containing two pore-forming P domains. This channel is an open rectifier which primarily passes outward current under physiological K+ concentrations. This gene is activated at alkaline pH. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.862
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNK17 | NM_031460.4 | c.221T>A | p.Leu74Gln | missense_variant | 1/5 | ENST00000373231.9 | NP_113648.2 | |
LOC105375047 | XR_926774.3 | n.145A>T | non_coding_transcript_exon_variant | 1/3 | ||||
KCNK17 | NM_001135111.2 | c.221T>A | p.Leu74Gln | missense_variant | 1/6 | NP_001128583.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNK17 | ENST00000373231.9 | c.221T>A | p.Leu74Gln | missense_variant | 1/5 | 1 | NM_031460.4 | ENSP00000362328 | P1 | |
KCNK17 | ENST00000503878.1 | n.326T>A | non_coding_transcript_exon_variant | 1/3 | 1 | |||||
KCNK17 | ENST00000453413.2 | c.221T>A | p.Leu74Gln | missense_variant | 1/6 | 5 | ENSP00000401271 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152000Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
152000
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000190 AC: 4AN: 210620Hom.: 0 AF XY: 0.0000172 AC XY: 2AN XY: 116526
GnomAD3 exomes
AF:
AC:
4
AN:
210620
Hom.:
AF XY:
AC XY:
2
AN XY:
116526
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000837 AC: 12AN: 1433412Hom.: 0 Cov.: 30 AF XY: 0.0000127 AC XY: 9AN XY: 710430
GnomAD4 exome
AF:
AC:
12
AN:
1433412
Hom.:
Cov.:
30
AF XY:
AC XY:
9
AN XY:
710430
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152000Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74258
GnomAD4 genome
AF:
AC:
1
AN:
152000
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74258
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3474
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2022 | The c.221T>A (p.L74Q) alteration is located in exon 1 (coding exon 1) of the KCNK17 gene. This alteration results from a T to A substitution at nucleotide position 221, causing the leucine (L) at amino acid position 74 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Pathogenic
D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M
MutationTaster
Benign
D;D
PrimateAI
Benign
T
PROVEAN
Pathogenic
D;D
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
D;.
Vest4
MutPred
Loss of stability (P = 0.0189);Loss of stability (P = 0.0189);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at